newsfilter
← Latest News
GlobeNewswire·

Kyverna Therapeutics Appoints Mayo Pujols as Chief Technology Officer

EMERYVILLE, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (NASDAQ:KYTX), a clinical stage biopharmaceutical company developing cell therapies for patients with autoimmune diseases, today